Clinical Trial Update: Effects of Eicosapentaenoic Acid on Subjects at High Risk for Colorectal Cancer [NA]

View source ↗

Summary

Completed clinical trial evaluating the effects of eicosapentaenoic acid in subjects with ulcerative colitis who are at high risk for colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Ulcerative Colitis

Drugs mentioned

• Eicosapentaenoic acid (eicosapentaenoic acid)

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Ulcerative Colitis | NA | Status: COMPLETED